You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 10,849,888


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,849,888 protect, and when does it expire?

Patent 10,849,888 protects ERLEADA and is included in one NDA.

This patent has sixty-seven patent family members in thirty-four countries.

Summary for Patent: 10,849,888
Title:Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
Abstract: Described herein are methods of treating non-metastatic castrate-resistant prostate cancer with anti-androgens.
Inventor(s): Chen; Isan (San Diego, CA)
Assignee: Aragon Pharmaceuticals, Inc. (San Diego, CA)
Application Number:16/033,432
Patent Claim Types:
see list of patent claims
Use; Delivery;

Drugs Protected by US Patent 10,849,888

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Janssen Biotech ERLEADA apalutamide TABLET;ORAL 210951-001 Feb 14, 2018 RX Yes No ⤷  Sign Up ⤷  Sign Up TREATMENT IN COMBINATION WITH ORCHIECTOMY OF NON-METASTATIC, CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) ⤷  Sign Up
Janssen Biotech ERLEADA apalutamide TABLET;ORAL 210951-002 Feb 17, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up TREATMENT IN COMBINATION WITH ORCHIECTOMY OF NON-METASTATIC, CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,849,888

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013323861 ⤷  Sign Up
Australia 2018206695 ⤷  Sign Up
Australia 2020244431 ⤷  Sign Up
Brazil 112015006705 ⤷  Sign Up
Canada 2885415 ⤷  Sign Up
Chile 2015000715 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.